Literature DB >> 11483557

Hypertensive therapy: attacking the renin-angiotensin system.

T Bishop1, V M Figueredo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11483557      PMCID： PMC1071503          DOI： 10.1136/ewjm.175.2.119

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  30 in total

Review 1.  15 years of heart-failure trials: what have we learned?

Authors:  B M Massie
Journal:  Lancet       Date:  1998-08       Impact factor: 79.321

Review 2.  The renin-angiotensin-aldosterone system: a specific target for hypertension management.

Authors:  M R Weir; V J Dzau
Journal:  Am J Hypertens       Date:  1999-12       Impact factor: 2.689

Review 3.  The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.

Authors:  C Venkata; S Ram; G Fierro
Journal:  Am J Ther       Date:  1998-03       Impact factor: 2.688

Review 4.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.

Authors:  G E Sander; J J McKinnie; S S Greenberg; T D Giles
Journal:  Prog Cardiovasc Dis       Date:  1999 Jan-Feb       Impact factor: 8.194

5.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.

Authors:  M J Domanski; D V Exner; C B Borkowf; N L Geller; Y Rosenberg; M A Pfeffer
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

6.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

Authors:  R S McKelvie; S Yusuf; D Pericak; A Avezum; R J Burns; J Probstfield; R T Tsuyuki; M White; J Rouleau; R Latini; A Maggioni; J Young; J Pogue
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

8.  Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure.

Authors:  G Hamroff; I Blaufarb; D Mancini; S D Katz; R Bijou; G Jondeau; M T Olivari; S Thomas; T H LeJemtel
Journal:  J Cardiovasc Pharmacol       Date:  1997-10       Impact factor: 3.105

9.  Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

Authors:  J V Gainer; J D Morrow; A Loveland; D J King; N J Brown
Journal:  N Engl J Med       Date:  1998-10-29       Impact factor: 91.245

10.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.